117 related articles for article (PubMed ID: 29143774)
1. Disrupting VEGF-VEGFR1 Interaction: De Novo Designed Linear Helical Peptides to Mimic the VEGF
Balsera B; Bonache MÁ; Reille-Seroussi M; Gagey-Eilstein N; Vidal M; González-Muñiz R; Pérez de Vega MJ
Molecules; 2017 Oct; 22(11):. PubMed ID: 29143774
[TBL] [Abstract][Full Text] [Related]
2. De novo designed library of linear helical peptides: an exploratory tool in the discovery of protein-protein interaction modulators.
Bonache MÁ; Balsera B; López-Méndez B; Millet O; Brancaccio D; Gómez-Monterrey I; Carotenuto A; Pavone LM; Reille-Seroussi M; Gagey-Eilstein N; Vidal M; de la Torre-Martinez R; Fernández-Carvajal A; Ferrer-Montiel A; García-López MT; Martín-Martínez M; de Vega MJ; González-Muñiz R
ACS Comb Sci; 2014 May; 16(5):250-8. PubMed ID: 24725184
[TBL] [Abstract][Full Text] [Related]
3. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
4. Parallel solid-phase synthesis of a small library of linear and hydrocarbon-bridged analogues of VEGF(81-91): potential biological tools for studying the VEGF/VEGFR-1 interaction.
García-Aranda MI; Marrero P; Gautier B; Martín-Martínez M; Inguimbert N; Vidal M; García-López MT; Jiménez MA; González-Muñiz R; Pérez de Vega MJ
Bioorg Med Chem; 2011 Mar; 19(6):1978-86. PubMed ID: 21349728
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
[TBL] [Abstract][Full Text] [Related]
6. On the structure, interactions, and dynamics of bound VEGF.
Horta BA; Cirino JJ; de Alencastro RB
J Mol Graph Model; 2008 Apr; 26(7):1091-103. PubMed ID: 18023381
[TBL] [Abstract][Full Text] [Related]
7. Helical peptides from VEGF and Vammin hotspots for modulating the VEGF-VEGFR interaction.
García-Aranda MI; González-López S; Santiveri CM; Gagey-Eilstein N; Reille-Seroussi M; Martín-Martínez M; Inguimbert N; Vidal M; García-López MT; Jiménez MA; González-Muñiz R; Pérez de Vega MJ
Org Biomol Chem; 2013 Mar; 11(11):1896-905. PubMed ID: 23381088
[TBL] [Abstract][Full Text] [Related]
8. C-terminal truncation of Vascular Endothelial Growth Factor mimetic helical peptide preserves structural and receptor binding properties.
Ziaco B; Diana D; Capasso D; Palumbo R; Celentano V; Di Stasi R; Fattorusso R; D'Andrea LD
Biochem Biophys Res Commun; 2012 Jul; 424(2):290-4. PubMed ID: 22749999
[TBL] [Abstract][Full Text] [Related]
9. Structural investigation of the VEGF receptor interaction with a helical antagonist peptide.
Diana D; Di Stasi R; De Rosa L; Isernia C; D'Andrea LD; Fattorusso R
J Pept Sci; 2013 Apr; 19(4):214-9. PubMed ID: 23420665
[TBL] [Abstract][Full Text] [Related]
10. Targeting diverse protein-protein interaction interfaces with α/β-peptides derived from the Z-domain scaffold.
Checco JW; Kreitler DF; Thomas NC; Belair DG; Rettko NJ; Murphy WL; Forest KT; Gellman SH
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4552-7. PubMed ID: 25825775
[TBL] [Abstract][Full Text] [Related]
11. Disulfide and amide-bridged cyclic peptide analogues of the VEGF₈₁₋₉₁ fragment: synthesis, conformational analysis and biological evaluation.
García-Aranda MI; Mirassou Y; Gautier B; Martín-Martínez M; Inguimbert N; Vidal M; García-López MT; Jiménez MA; González-Muñiz R; Pérez de Vega MJ
Bioorg Med Chem; 2011 Dec; 19(24):7526-33. PubMed ID: 22078412
[TBL] [Abstract][Full Text] [Related]
12. Structural studies of the binding of an antagonistic cyclic peptide to the VEGFR1 domain 2.
Wang L; Coric P; Broussy S; Di Stasi R; Zhou L; D'Andrea LD; Ji L; Vidal M; Bouaziz S; Liu WQ
Eur J Med Chem; 2019 May; 169():65-75. PubMed ID: 30856407
[TBL] [Abstract][Full Text] [Related]
13. VEGFR1 domain 2 covalent labeling with horseradish peroxidase: Development of a displacement assay on VEGF.
Reille-Seroussi M; Gaucher JF; Cussac LA; Broutin I; Vidal M; Broussy S
Anal Biochem; 2017 Aug; 530():107-112. PubMed ID: 28477965
[TBL] [Abstract][Full Text] [Related]
14. 111In- or 99mTc-labeled recombinant VEGF bioconjugates: in vitro evaluation of their cytotoxicity on porcine aortic endothelial cells overexpressing Flt-1 receptors.
Chan C; Cai Z; Su R; Reilly RM
Nucl Med Biol; 2010 Feb; 37(2):105-15. PubMed ID: 20152709
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1.
Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S
PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of angiogenesis by D,L-peptides derived from vascular endothelial growth factor receptor 2.
Piossek C; Thierauch KH; Schneider-Mergener J; Volkmer-Engert R; Bachmann MF; Korff T; Augustin HG; Germeroth L
Thromb Haemost; 2003 Sep; 90(3):501-10. PubMed ID: 12958620
[TBL] [Abstract][Full Text] [Related]
17. Modulation, bioinformatic screening, and assessment of small molecular peptides targeting the vascular endothelial growth factor receptor.
Feng S; Zou L; Ni Q; Zhang X; Li Q; Zheng L; Xie L; Li H; Huang D
Cell Biochem Biophys; 2014 Dec; 70(3):1913-21. PubMed ID: 25069724
[TBL] [Abstract][Full Text] [Related]
18. Biophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A.
Gaucher JF; Reille-Seroussi M; Gagey-Eilstein N; Broussy S; Coric P; Seijo B; Lascombe MB; Gautier B; Liu WQ; Huguenot F; Inguimbert N; Bouaziz S; Vidal M; Broutin I
PLoS One; 2016; 11(12):e0167755. PubMed ID: 27942001
[TBL] [Abstract][Full Text] [Related]
19. Structure of the Full-length VEGFR-1 Extracellular Domain in Complex with VEGF-A.
Markovic-Mueller S; Stuttfeld E; Asthana M; Weinert T; Bliven S; Goldie KN; Kisko K; Capitani G; Ballmer-Hofer K
Structure; 2017 Feb; 25(2):341-352. PubMed ID: 28111021
[TBL] [Abstract][Full Text] [Related]
20. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
